KAT2A and neoplasm: We observed that metastatic burden was dramatically reduced in the absence of KAT2a expression compared to control (Figure 7f, Extended Data Figure 5a), while primary tumor growth showed only a small reduction compared to control (Extended Data Figure 5b).